Reivas Pharmaceutical Private Limited
About Reivas Pharmaceutical Private Limited
Data last updated:
Reivas Pharmaceutical Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U24299JH2019PTC012837. Its GSTIN is 20AAJCR5428D1ZQ (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rupesh Mishra and Ayush Prasad.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Arun Kumar Mehta Ward No – 33 Khata No. 17 Plot No. 135 Thana No. 202, Ranchi, Jharkhand, India – 834005.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.74 Lakh, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹31,120 (net margin 1%) and EBITDA of ₹81,031 (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
Company details
Contact details
Reivas Pharmaceutical Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Arun Kumar Mehta Ward No – 33 Khata No. 17 Plot No. 135 Thana No. 202, Ranchi, Jharkhand, India – 834005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reivas Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reivas Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reivas Pharmaceutical Private Limited, buy the company report.
Financials of Reivas Pharmaceutical Private Limited
FY 2024 filings availableReivas Pharmaceutical Private Limited reported revenue of ₹32.74 Lakh (up 79% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over three years, including 79% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81,031 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,120 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reivas Pharmaceutical Private Limited, buy the company report.
Board of directors of Reivas Pharmaceutical Private Limited
Reivas Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupesh Mishra | Director | 15 Apr 2019 | 7 Years 6 Months | Current |
| Ayush Prasad | Additional Director | 06 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Reivas Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lords Hospitality Equipments Private Limited | ₹32.75 Lakh (FY 2024) | 20.0% | Nagpur, Maharashtra, India | |||
| Gora Marine Private Limited | ₹32.75 Lakh (FY 2022) | -92.0% | Bhavnagar, Gujarat, India | |||
| Greemer Biotics Private Limited | ₹32.75 Lakh (FY 2024) | 0.0% | Kottayam, Kerala, India | |||
| Daffodil Traders Private Limited | ₹32.74 Lakh (FY 2020) | 9.0% | Howrah, West Bengal, India | |||
| Avenue Health Cure Private Limited | ₹32.74 Lakh (FY 2024) | 269.0% | Mysore, Karnataka, India | |||
| Reivas Pharmaceutical Private Limitedthis company | ₹32.74 Lakh (FY 2024) | ₹31,120 | 1% | 79.0% | Ranchi, Jharkhand, India | |
| Swastik Trade & Agencies Private Limited | ₹32.74 Lakh (FY 2021) | 8.0% | Guwahati, Assam, India | |||
| Cigar Club India Private Limited | ₹32.73 Lakh (FY 2025) | 55.0% | Bangalore, Karnataka, India | |||
| Sunrise Decor & Gifts Private Limited | ₹32.73 Lakh (FY 2024) | -40.0% | Delhi, India | |||
| Saatvik Papers Private Limited | ₹32.73 Lakh (FY 2023) | 144.0% | Guwahati, Assam, India | |||
| Mench Technologies Private Limited | ₹32.73 Lakh (FY 2023) | 51.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Reivas Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reivas Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reivas Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reivas Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAJCR5428D1ZQ | Jharkhand | Active | 01 Jul 2019 |
To see the full GST registrations and return filing status of Reivas Pharmaceutical Private Limited, buy the company report.
Recent activity
Reivas Pharmaceutical Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Nilesh Kumar Mishra ceased to be Director on 10 Jan 2025.
Frequently asked questions
Reivas Pharmaceutical is an active private limited company based in Ranchi, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 April 2019 (7+ years old) and is registered under CIN U24299JH2019PTC012837.
Reivas Pharmaceutical has 2 current directors:
- Rupesh Mishra - Director
- Ayush Prasad - Additional Director
The latest financial statements of Reivas Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Reivas Pharmaceutical is 20AAJCR5428D1ZQ, registered in Jharkhand.
The CIN (Corporate Identification Number) of Reivas Pharmaceutical is U24299JH2019PTC012837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reivas Pharmaceutical was incorporated on 15 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Reivas Pharmaceutical by revenue are Lords Hospitality Equipments Private Limited, Gora Marine Private Limited, Greemer Biotics Private Limited, Daffodil Traders Private Limited, Avenue Health Cure Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nilesh Kumar Mishra ceased to be Director on 10 Jan 2025. Ayush Prasad was appointed as Additional Director on 06 Jan 2025. Bikash Kumar Gupta ceased to be Additional Director on 02 Nov 2023. Reivas Pharmaceutical has 8 board changes on record in total.
The registered office of Reivas Pharmaceutical is at CO Arun Kumar Mehta Ward No – 33 Khata No. 17 Plot No. 135 Thana No. 202, Ranchi, Jharkhand, India – 834005.
Reivas Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Reivas Pharmaceutical can be reached at its registered office: CO Arun Kumar Mehta Ward No – 33 Khata No. 17 Plot No. 135 Thana No. 202, Ranchi, Jharkhand, India – 834005.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
